Micro&immunity - Lec-11
Micro&immunity - Lec-11
S
01556364241
General Microbiology
& Immunology
Lec-11
Immunology
Level -2
Pharm -D
B cell-mediated immune response
• naive B cells circulate throughout the body via the lymphatic system.
• These cells produce antigen-specific molecules that are necessary for detecting infectious pathogens in the human body.
• When naive B cells in the lymphatic system come into contact with an antigen, they begin the differentiation process that results in the formation of memory
B cells and effector B cells.
• Memory B cells and effector B cells produce the same antigen-specific molecules as their parent naive B cell during this development.
• The activated memory B cells express these antigen-specific molecules on their surface with the help of T cell lymphocytes, which are activated by MHC
class II receptors that recognize microbial-associated antigens.
• The effector B cells secrete these molecules in the blood to bind the antigen of interest.
✓ naive B-cells exit bone marrow, migrate to secondary lymphoid organs, then express both
surface IgM and IgD
✓ naive B-cells recirculate between blood and lymphoid organs, entering B cell follicles in
B-Cell Activation lymph nodes and spleen, responding to antigen encounter with T cell help, leading to
antibody production.
✓ B cells then interact with exogenous antigen and/or T helper cells
➢ antigen dependent phase
Are small molecules which could never induce an immune response when
administered by themselves but which can when coupled to a carrier molecule
Haptens Incomplete
antigen (posses only immunoreactivity but has not immunogenicity), Ex: Penicillin
Antigen determinants the portion of antigen molecules which can be specifically bound by antibody or lymphocyte receptor (TCR or BCR).
(epitopes):
▪ The valency of antibody refers to the number of antigenic determinants (epitopes) that an individual antibody molecule can bind.
Valency ▪ The valency of all antibodies is at least two and in some instances more.
Antibodies Immunoglobulins
• All immunoglobulins have a four chain structure as their basic unit. They are
composed of two identical light chains (23 kDa) and two identical heavy
chains (50-70 kDa).
• There are five types of Ig heavy chain (in mammal) denoted by the Greek
A. Heavy and Light letters: α, δ, ε, γ, and μ.
Chains • There are two types of Ig light chain (in mammal), which are called lambda
(A) and kappa (k).
1. Inter-chain The heavy and light chains and the two heavy chains are held
together by inter-chain disulfide bonds interactions. The number of inter-
B. Disulfide bonds chain disulfide bonds varies among different immunoglobulin molecules.
2. Intra-chain Within each of the polypeptide chains there are also intra-chain
disulfide bonds.
Both the heavy and light chain could be divided into two regions based on variability in the amino
C. Variable (V) and
acid sequences:
Constant (C) Regions
1. Light Chain - VL (110 aa) and L (110 aa)
2. Heavy Chain - VH (110 aa) and CH (330-440 aa)
The region at which the arms of the antibody molecule forms a Y is called the hinge region because there is some flexibility in the
D. Hinge Region molecule at this point.
Structural Regions
Immunoglobulin fragments
Structural/function relationships
Immunoglobulin fragments produced by proteolytic digestion have proven very useful in elucidating structure/function
relationships in immunoglobulins.
▪ Fragment of Ag binding
▪ Digestion with papain breaks the immunoglobulin molecule in the hinge region before
1- Fab the H-H inter-chain disulfide bond. This results in the formation of two identical
fragments that contain the light chain and the VH and CHI domains of the heavy chain.
Two units monovalent
▪ Fragment of constant
region (crystallized)
▪ Digestion with papain
also produces a
fragment that contains
2. Fc the remainder of the
two heavy chains each containing a CH2 and CH3
domain. This fragment was called Fc because it
was easily crystallized.
▪ Effector functions The effector functions of immunoglobulins are mediated by this part of the
molecule. Different functions are mediated by the different domains in this fragment
▪ Treatment of immunoglobulins with pepsin results in cleavage of the heavy chain after the H-
H inter-chain disulfide bonds resulting in a fragment that contains both antigen binding sites.
▪ This fragment was called F(ab')2 because it was divalent.
▪ The Fe region of the molecule is digested into small peptides by pepsin. The F(ab')2 binds
antigen but it does not mediate the effector functions of antibodies.
3. F(ab')2
▪ Often the binding of an antibody to an antigen has no direct biological effect. The
significant biological effects are a consequence of secondary "effector functions" of
antibodies.
2. Effector Functions ▪ The immunoglobulins mediate a variety of these effector functions. Usually the ability to
carry out a particular effector function requires that the antibody binds to its antigen.
Not every immunoglobulin will mediate all effector functions. Such effector functions include
1- Fixation of complement: This results in lysis of cells, release of biologically active molecules
2- Binding to various cell types
▪ Phagocytic cells. NK, mast cells, and basophils have receptors that bind immunoglobulins and the binding can
activate the cells to perform some function.
▪ Some immunoglobulins also bind to receptors on placental trophoblasts. The binding results in transfer of the
immunoglobulin across the placenta and the transferred maternal antibodies provide immunity to the fetus and
newborn
▪
Antibody to diphtheria toxin (antitoxin) can
prevent the binding of the toxin to host cells
thereby neutralize the biological effects of
diphtheria toxin
▪ Opsonization involves the binding of an opsonin, e.g..
antibody, to a receptor on the pathogen's cell
3. Opsonization membrane. After opsonin binds to the membrane,
phagocytes are attracted to the pathogen.